首页> 外文期刊>BMC Neurology >Clinico-pathogenetic findings and management of chondrodystrophic myotonia (Schwartz-Jampel syndrome): a case report
【24h】

Clinico-pathogenetic findings and management of chondrodystrophic myotonia (Schwartz-Jampel syndrome): a case report

机译:软骨营养不良性肌强直(Schwartz-Jampel综合征)的临床病理发现和管理:一例报告

获取原文
           

摘要

Background Chondrodystrophic myotonia or Schwartz-Jampel syndrome is a rare genetic disorder characterized by myotonia and skeletal dysplasia. It may be progressive in nature. Recently, the gene responsible for Schwartz-Jampel syndrome has been found and the defective protein it encodes leads to abnormal cartilage development and anomalous neuromuscular activity. Case Presentation We report the clinical findings and the management of an 8-year-old boy with this disorder. The molecular findings confirm that the patient is a compound heterozygote with a different splicing mutation in each Perlecan allele. This resulted in a significant reduction in the production of the encoded normal protein. Conclusion We discuss the multi-disciplinary management of Schwartz-Jampel syndrome that will facilitate optimal care and timely intervention of patients with this disorder.
机译:背景软骨营养不良性肌强直或Schwartz-Jampel综合征是一种以肌强直和骨骼发育不良为特征的罕见遗传疾病。它本质上可能是进步的。最近,已经发现了负责Schwartz-Jampel综合征的基因,该基因编码的缺陷蛋白导致软骨发育异常和神经肌肉活动异常。病例介绍我们报告了一名8岁男孩患有这种疾病的临床发现和处理方法。分子发现证实该患者是在每个Perlecan等位基因中具有不同剪接突变的复合杂合子。这导致编码的正常蛋白的产生显着减少。结论我们讨论了Schwartz-Jampel综合征的多学科治疗,这将有助于对该疾病患者的最佳护理和及时干预。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号